The Pittsburgh Foundation Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2003
NCT01042691
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

The Pittsburgh Foundation